Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Read More
Pepperdine Graziadio Business School
Siren Biotechnology named a 2025 Most Fundable Company
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 11.9.23
Webinar – Proactive Strategies for Biotech Success in the 2024 Landscape
Read More
Press Releases
|
Posted on 11.1.23
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Read More
Media Coverage
|
Posted on 10.4.23
2023 All-In Summit – A discussion on the future of gene therapy
Read More
Media Coverage
|
Posted on 9.13.23
Webinar – The State of Biotech 2023
Read More
Media Coverage
|
Posted on 8.24.23
Developing universal AAV immuno-gene therapy for oncology
Read More
Media Coverage
|
Posted on 5.18.23
New biotech Siren calls for gene therapy and cancer to ‘get into the weeds together’
Read More
Media Coverage
|
Posted on 5.17.23
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
Read More
Media Coverage
|
Posted on 5.17.23
Nicole Paulk’s Siren Bio is building a gene therapy delivery vehicle against cancer
Read More
Media Coverage
|
Posted on 5.17.23
ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology
Read More
Media Coverage
|
Posted on 5.17.23
A new startup looks to turn the workhorse of gene therapy against cancer
Read More
1
2
3
4
5
